Downregulation of CIC does not associate with overexpression of ETV1 or MAP kinase pathway activation in gastrointestinal stromal tumors

Cancer Investigation

Volumn 32, Issue 7, 2014, Pages 363-367

  Schoppmann, Sebastian F ^a,c   Ricken, Gerda ^a   Ilhan Mutlu, Aysegül ^a,c   Nirtl, Nadine ^d   Streubel, Berthold ^b,c   Preusser, Matthias ^a,c   Birner, Peter ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^c Austrian Breast and Colorectal Cancer Study Group   (Austria)

^d Fachhochschule Campus Wien   (Austria)

Author keywords

19q; CIC; ETV1; GIST; KIT; MAPK

Indexed keywords

CIC PROTEIN; IMATINIB; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN; TRANSCRIPTION FACTOR ER81; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CHROMOSOME 19; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

19Q; CIC; ETV1; GIST; KIT; MAPK;

CHROMOSOMES, HUMAN, PAIR 19; DNA COPY NUMBER VARIATIONS; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; GASTROINTESTINAL TRACT; GENE DOSAGE; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84903961721     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2014.919304     Document Type: Article

References (31)

1. Paral J, Slaninka I, Kalabova H, Hadzi-Nikolov D. Gastrointestinal stromal tumors: review on morphology, molecular pathology, diagnostics, prognosis and treatment options. Acta Gastroenterol Belg 2010;73: 349-359.
2. Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R, Hibbard MK, Chen CJ, Xiao S, Tuveson DA, Demetri GD, Fletcher CD, Fletcher JA. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 2001;61: 8118-8121. (Pubitemid 33091601)
3. Pisters PW, Colombo C. Adjuvant imatinib therapy for gastrointestinal stromal tumors. J Surg Oncol 2011;104: 896-900.
4. Blay JY. Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib. Ann Oncol 2010;21: 208-215.
5. Agulnik M, Giel JL. Understanding rechallenge and resistance in the tyrosine kinase inhibitor era: imatinib in gastrointestinal stromal tumor. Am J Clin Oncol. Epub 2012 Jul 3.
6. Miranda C, Nucifora M, Molinari F, Conca E, Anania MC, Bordoni A, Saletti, P, Mazzucchelli L, Pilotti S, Pierotti MA, Tamborini E, Greco A, Frattini M. KRAS and BRAFmutations predict primary resistance to imatinib in gastrointestinal stromal tumors. Clin Cancer Res 2012;18: 1769-1776.
7. Chi P, Chen Y, Zhang L, Guo X, Wongvipat J, Shamu T, Fletcher JA, Dewell S, Maki RG, Zheng D, Antonescu CR, Allis CD, Sawyers CL. ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours. Nature 2010;467: 849-853.
8. Birner P, Beer A, Vinatzer U, Stary S, Hoftberger R, Nirtl N, Wrba F, Streubel B, Schoppmann SF. MAPKAP kinase 2 overexpression influences prognosis in gastrointestinal stromal tumors and associates with copy number variations on chromosome 1 and expression of p38 MAP kinase and ETV1. Clin Cancer Res 2012;18: 1879-1887.
9. Dissanayake K, Toth R, Blakey J, Olsson O, Campbell DG, Prescott AR, Mac Kintosh C. ERK/p90(RSK)/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicua. Biochem J 2011;433: 515-525.
10. Kim Y, Andreu MJ, Lim B, Chung K, Terayama M, Jimenez G, Berg CA, Lu H, Shvartsman SY. Gene regulation by MAPK substrate competition. Dev Cell 2011;20: 880-887.
11. Astigarraga S, Grossman R, Diaz-Delfin J, Caelles C, Paroush Z, Jimenez G. A MAPK docking site is critical for downregulation of Capicua by Torso and EGFR RTK signaling. Embo J 2007;26: 668-677.
12. Kim Y, Coppey M, Grossman R, Ajuria L, Jimenez G, Paroush Z, Shvartsman SY. MAPK substrate competition integrates patterning signals in the Drosophila embryo. Curr Biol 2010;20: 446-451.
13. Duensing A, Medeiros F, Mc Conarty B, Joseph NE, Panigrahy D, Singer S, Fletcher CD, Demetri GD, Fletcher JA. Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). Oncogene 2004;23: 3999-4006. (Pubitemid 38747928)
14. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33: 459-465. (Pubitemid 34747864)
15. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006;23: 70-83. (Pubitemid 44692418)
16. Schoppmann SF, Beer A, Nirtl N, Ba-Ssalamah A, Brodowicz T, Streubel B, Birner P. Downregulation of phosphatidylethanolamine binding protein 1 associates with clinical risk factors in gastrointestinal stromal tumors, but not with activation of the RAF-1-MEK-ETV1 pathway. Cancer Lett 2013;335: 26-30.
17. Schoppmann SF, Berghoff AS, Jesch B, Zacherl J, Nirtl N, Jomrich G, Maroske F, Streubel B, Mesteri I, Birner P. Expression of podoplanin is a rare event in sporadic gastrointestinal stromal tumors and does not influence prognosis. Future Oncol 2012;8: 859-866.
18. Schoppmann SF, Vinatzer U, Popitsch N, Mittlbock M, Liebmann- Reindl S, Jomrich G, Streubel B, Birner P. Novel clinically relevant genes in gastrointestinal stromal tumors identified by exome sequencing. Clin Cancer Res 2013;19: 5329-5339.
19. Jimenez G, Guichet A, Ephrussi A, Casanova J. Relief of gene repression by torso RTK signaling: role of capicua in Drosophila terminal and dorsoventral patterning. Genes Dev 2000;14: 224-231. (Pubitemid 30070987)
20. Jimenez G, Shvartsman SY, Paroush Z.The Capicua repressor - a general sensor of RTKsignaling indevelopment anddisease. J Cell Sci 2012;125: 1383-1391.
21. Tseng AS, Tapon N, Kanda H, Cigizoglu S, Edelmann L, Pellock B, White K, Hariharan IK. Capicua regulates cell proliferation downstreamof the receptor tyrosine kinase/ras signaling pathway. Curr Biol 2007;17: 728-733. (Pubitemid 46552255)
22. Lee CJ, Chan WI, Scotting PJ. CIC, a gene involved in cerebellar development and Erb B signaling, is significantly expressed in medulloblastomas. J Neurooncol 2005;73: 101-108. (Pubitemid 40974029)
23. Bettegowda C, Agrawal N, Jiao Y, Sausen M, Wood LD, Hruban RH, Rodriguez FJ, Cahill DP, Mc Lendon R, Riggins G, Velculescu VE, Oba-Shinjo SM, Marie SK, Vogelstein B, Bigner D, Yan H, Papadopoulos N, Kinzler KW. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 2011;333: 1453-1455.
24. Kawamura-Saito M, Yamazaki Y, Kaneko, K, Kawaguchi N, Kanda H, Mukai H, Gotoh T, Motoi T, Fukayama M, Aburatani H, Takizawa T, Nakamura T. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet 2006;15: 2125-2137. (Pubitemid 43923402)
25. Monte D, Coutte L, Baert JL, Angeli I, Stehelin D, de Launoit Y. Molecular characterization of the ets-related human transcription factor ER81. Oncogene 1995;11: 771-779.
26. Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 1995;10: 1229-1234.
27. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310: 644-648. (Pubitemid 41528150)
28. Jane-Valbuena J, Widlund HR, Perner S, Johnson LA, Dibner AC, Lin WM, Baker AC, Nazarian RM, Vijayendran KG, Sellers WR, Hahn WC, Duncan LM, Rubin MA, Fisher DE, Garraway LA. An oncogenic role for ETV1 in melanoma. Cancer Res 2010;70: 2075-2084.
29. Antonescu CR, Besmer P, Guo T, Arkun K, Hom G, Koryotowski B, Leversha MA, Jeffrey PD, Desantis D, Singer S, Brennan MF, Maki RG, De Matteo RP. Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res 2005;11: 4182-4190. (Pubitemid 40791584)
30. Knuutila S, Armengol G, Bjorkqvist AM, el-Rifai W, Larramendy ML, Monni O, Szymanska J. Comparative genomic hybridization study on pooled DNAs from tumors of one clinical-pathological entity. Cancer Genet Cytogenet 1998;100: 25-30. (Pubitemid 128766338)
31. Agaimy A, Pelz AF, Corless CL, Wunsch PH, Heinrich MC, Hofstaedter F, Dietmaier W, Blanke CD, Wieacker P, Roessner A, Hartmann A, Schneider-Stock R. Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridization. Oncol Rep 2007;18: 9-15.